Stock INO INOVIO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Inovio Pharmaceuticals, Inc.

Equities

INO

US45773H4092

Real-time Estimate Cboe BZX
Other stock markets
 01:14:04 2024-05-09 pm EDT 		5-day change 1st Jan Change
11.16 USD +1.41% Intraday chart for Inovio Pharmaceuticals, Inc. -7.24% +82.03%
Apr. 16 Powell Comments, Middle East Tensions in Focus as US Equity Futures Gain Pre-Bell MT
Apr. 16 Inovio Pharmaceuticals Shares Slump Pre-Bell After Pricing of $36 Million Offering of Common Stock, Warrants MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
INOVIO Reports Inducement Grants Under Inducement Plan
PR
INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
PR
INOVIO to Participate in Upcoming Investor Conferences in May
PR
Powell Comments, Middle East Tensions in Focus as US Equity Futures Gain Pre-Bell
MT
Inovio Pharmaceuticals Shares Slump Pre-Bell After Pricing of $36 Million Offering of Common Stock, Warrants
MT
Top Premarket Decliners
MT
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
PR
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
PR
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
AQ
Transcript : Inovio Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 06, 2024
Inovio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
PR
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PR
INOVIO Reports Inducement Grant Under Inducement Plan
PR
Oppenheimer Upgrades Inovio Pharmaceuticals to Outperform From Perform, $4 Price Target
MT
Reverse Split: 1 of 12
FA
Transcript : Inovio Pharmaceuticals, Inc. - Special Call
INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split
PR
INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader
PR
Inovio Pharmaceuticals, Coherus BioSciences to Collaborate on Potential Throat Cancer Treatment
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INO Stock
  4. News Inovio Pharmaceuticals, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW